title: NleC, a type III secretion protease, compromises NF-κB activation by targeting p65/RelA.
abstract: The NF-κB signaling pathway is central to the innate and adaptive immune responses. Upon their detection of pathogen-associated molecular patterns, Toll-like receptors on the cell surface initiate signal transduction and activate the NF-κB pathway, leading to the production of a wide array of inflammatory cytokines, in attempt to eradicate the invaders. As a countermeasure, pathogens have evolved ways to subvert and manipulate this system to their advantage. Enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and EHEC) are closely related bacteria responsible for major food-borne diseases worldwide. Via a needle-like protein complex called the type three secretion system (T3SS), these pathogens deliver virulence factors directly to host cells and modify cellular functions, including by suppressing the inflammatory response. Using gain- and loss-of-function screenings, we identified two bacterial effectors, NleC and NleE, that down-regulate the NF-κB signal upon being injected into a host cell via the T3SS. A recent report showed that NleE inhibits NF-κB activation, although an NleE-deficient pathogen was still immune-suppressive, indicating that other anti-inflammatory effectors are involved. In agreement, our present results showed that NleC was also required to inhibit inflammation. We found that NleC is a zinc protease that disrupts NF-κB activation by the direct cleavage of NF-κB's p65 subunit in the cytoplasm, thereby decreasing the available p65 and reducing the total nuclear entry of active p65. More importantly, we showed that a mutant EPEC/EHEC lacking both NleC and NleE (ΔnleC ΔnleE) caused greater inflammatory response than bacteria carrying ΔnleC or ΔnleE alone. This effect was similar to that of a T3SS-defective mutant. In conclusion, we found that NleC is an anti-inflammatory bacterial zinc protease, and that the cooperative function of NleE and NleC disrupts the NF-κB pathway and accounts for most of the immune suppression caused by EHEC/EPEC.
authors.affiliation: Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
authors.forename: Hilo
authors.initials: H
authors.lastname: Yen
authors.forename: Tadasuke
authors.initials: T
authors.lastname: Ooka
authors.forename: Atsushi
authors.initials: A
authors.lastname: Iguchi
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Hayashi
authors.forename: Nakaba
authors.initials: N
authors.lastname: Sugimoto
authors.forename: Toru
authors.initials: T
authors.lastname: Tobe
mesh_terms: D054324:Enterohemorrhagic Escherichia coli / Q000472:pathogenicity*; D054308:Enteropathogenic Escherichia coli / Q000472:pathogenicity*; D029968:Escherichia coli Proteins / Q000502:physiology*; D057131:Immune Evasion; D016328:NF-kappa B / Q000037:antagonists & inhibitors* / Q000378:metabolism; D010447:Peptide Hydrolases; D051996:Transcription Factor RelA / Q000037:antagonists & inhibitors*; D037521:Virulence Factors / Q000502:physiology
chemical_list: D029968:Escherichia coli Proteins; D016328:NF-kappa B; C526043:NleE protein, E coli; D051996:Transcription Factor RelA; D037521:Virulence Factors; C506688:Z0986 protein, E coli; D010447:Peptide Hydrolases